title: A chronic high fat diet alters the homologous and heterologous control of appetite regulating peptide receptor expression.
abstract: Leptin, ghrelin and neuropeptide W (NPW) modulate vagal afferent activity, which may underlie their appetite regulatory actions. High fat diet (HFD)-induced obesity induces changes in the plasma levels of these peptides and alters the expression of receptors on vagal afferents. We investigated homologous and heterologous receptor regulation by leptin, ghrelin and NPW. Mice were fed (12 weeks) a standard laboratory diet (SLD) or HFD. Nodose ganglia were cultured overnight in the presence or absence of each peptide. Leptin (LepR), ghrelin (GHS-R), NPW (GPR7) and cholecystokinin type-1 (CCK1R) receptor mRNA, and the plasma leptin, ghrelin and NPW levels were measured. SLD: leptin reduced LepR, GPR7, increased GHS-R and CCK1R mRNA; ghrelin increased LepR, GPR7, CCK1R, and decreased GHS-R. HFD: leptin decreased GHS-R and GPR7, ghrelin increased GHS-R and GPR7. NPW decreased all receptors except GPR7 which increased with HFD. Plasma leptin was higher and NPW lower in HFD. Thus, HFD-induced obesity disrupts inter-regulation of appetite regulatory receptors in vagal afferents.
authors.affiliation: Nerve Gut Research Laboratory, Department of Medicine, University of Adelaide, Frome Road, Adelaide, SA 5005, Australia.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Kentish
authors.forename: Gary A
authors.initials: GA
authors.lastname: Wittert
authors.forename: L Ashley
authors.initials: LA
authors.lastname: Blackshaw
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Page
mesh_terms: D000818:Animals; D001066:Appetite / Q000502:physiology*; D001069:Appetite Regulation / Q000502:physiology*; D002478:Cells, Cultured; D059305:Diet, High-Fat; D005260:Female; D054439:Ghrelin / Q000097:blood* / Q000378:metabolism; D020738:Leptin / Q000097:blood* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009479:Neuropeptides / Q000097:blood* / Q000378:metabolism; D009620:Nodose Ganglion / Q000166:cytology / Q000187:drug effects; D009765:Obesity / Q000097:blood; D012333:RNA, Messenger; D043886:Receptor, Cholecystokinin A / Q000235:genetics; D043562:Receptors, G-Protein-Coupled / Q000096:biosynthesis / Q000378:metabolism; D054440:Receptors, Ghrelin / Q000378:metabolism; D054411:Receptors, Leptin / Q000378:metabolism; D018013:Receptors, Neuropeptide / Q000096:biosynthesis / Q000378:metabolism; D014630:Vagus Nerve / Q000378:metabolism
chemical_list: D054439:Ghrelin; D020738:Leptin; D009479:Neuropeptides; C485721:Npbwr1 protein, mouse; D012333:RNA, Messenger; D043886:Receptor, Cholecystokinin A; D043562:Receptors, G-Protein-Coupled; D054440:Receptors, Ghrelin; D054411:Receptors, Leptin; D018013:Receptors, Neuropeptide; C508547:neuropeptide W, mouse
keywords: CCK; CCK1R; ELISA; GHS-R; GPR7; Ghrelin; HBSS; HFD; HFD-induced obesity; Hank's Balanced Salt Solution; LepR; Leptin; NBA; NPW; Neurobasal A medium; PBS; Receptors; SLD; SOC3; STAT3; cholecystokinin; cholecystokinin type 1 receptor; enzyme-linked immunosorbent assay; ghrelin receptor; high fat diet; leptin receptor; neuropeptide W; neuropeptide W receptor; phosphate buffered saline; signal transducer and activator of transcription 3; standard laboratory diet; suppressor of cytokine signaling 3